We will set up a booth at CPHI Japan 2025

Luxna and SPI Announce License Agreement for manufacturing and sales of Luxna’s xeno modified nucleic acid amidite

Inocras and Summit Pharmaceuticals International Corporation Announce Collaboration aim to Transform Clinical Genomics in Japan

Summit Pharmaceuticals International Corporation Invests in EVerMed Inc.

Summit Pharmaceuticals International Corporation Statement for UK Modern Slavery Act 2015 (FY 2023 Statement)

SPI Earns Silver Medal in EcoVadis Sustainability Assessment

Signing of the United Nations Global Compact

Signed an Exclusive Distributorship Agreement with Texcell

We will set up a booth at CPHI Japan 2024（Ended）

Website renewal

Summit Pharmaceuticals International Corporation Statement for UK Modern Slavery Act 2015 (FY 2022 Statement)

Signing of Exclusive Distributorship Agreement with EVERZOM